Get started
Award

Development of New Therapies for Huntington's Disease

Funding type: cooperative_agreement
Funder scheme: U01
Start date: 2004-07-01
End date: 2009-04-30
Investigator: M FLINT BEAL
Institution: WEILL MEDICAL COLL OF CORNELL UNIV
Funded outputs count: 4
Funder award ID: U01NS049077
OpenAlex ID: G7990469110
Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease
2010 · Cliona Stack, Daniel Ho, et al. · Free Radical Biology and Medicine · 175
Combination therapy with Coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s Diseases
2009 · Lichuan Yang, Noel Y. Calingasan, et al. · Journal of Neurochemistry · 237
Oxidative Damage in Huntington's Disease Pathogenesis
2006 · Susan E. Browne, M. Flint Beal · Antioxidants and Redox Signaling · 313
Mitochondria take center stage in aging and neurodegeneration
2005 · M. Flint Beal · Annals of Neurology · 966
PDF
Year
Topic